Skip to main content
. 2014 Apr 5;2(1):1–14.

Table 1.

Summary of urine biomarkers for bladder cancer diagnosis and surveillance

Test Markers Sensitivity* Specificity*
Cytology Urothelial cells 30-92% 93-97%
ImmunoCyt Urothelial cell and immunostain 55-90% 33-87%
Urovysion FISH 51-92% 55-95%
BTA stat (point-of-care) and BTA-TRAK Bladder Tumor Antigen 36-91% 50-90%
BladderCheck (point-of-care) and Bladder Cancer Test NMP22 34-95% 55-85%
ACCU-DX (point-of-care) FDP 60-83% 80-86%
*

Vary between low grade and high grade urothelial carcinoma.